Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies

Abstract The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Puneet Rawat, Divya Sharma, Ambuj Srivastava, Vani Janakiraman, M. Michael Gromiha
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/91d1b92f687040aebb2d043b3dfc7e60
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!